References
- Leroy EM, Ar Gouilh M, Brugère-Picoux J. The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic. One Heal. 2020;10:4–7.
- McNamara T, Richt JA, Glickman L. A critical needs assessment for research in companion animals and livestock following the pandemic of COVID-19 in humans. Vector-Borne Zoonotic Dis. 2020;20(6):393–405.
- Stout AE, André NM, Jaimes JA, et al. Coronaviruses in cats and other companion animals: where does SARS-CoV- T 2/COVID-19 fit? Vet Microbiol. 2020;247:108777.
- Murphy HL, Ly H. Understanding the prevalence of SARS-CoV-2 (COVID-19) exposure in companion, captive, wild, and farmed animals. Virulence. 2021;12(1):2777–2786.
- Goryoka GW, Cossaboom CM, Gharpure R, et al. One health investigation of sars-cov-2 infection and seropositivity among pets in households with confirmed human covid-19 cases—Utah and Wisconsin, 2020. Viruses. 2021;13(9):1813. DOI:10.3390/v13091813
- Calvet GA, Pereira SA, Ogrzewalska M, et al. Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil. PLoS One. 2021;16(4):1–21. DOI:10.1371/journal.pone.0250853
- Patterson EI, Elia G, Grassi A, et al. Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy. Nat Commun. 2020;11(1):1–5. DOI:10.1038/s41467-020-20097-0
- Garigliany M, Van Laere A-S, Clercx C, et al. SARS-CoV-2 natural transmission from human to Cat, Belgium, March 2020. Emerg Infect Dis. 2020;26(12):3069–3071. DOI:10.3201/eid2612.202223
- Dileepan M, Di D, Huang Q, et al. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA. Virulence. 2021;12(1):1597–1609. DOI:10.1080/21505594.2021.1936433
- The New York Times. Tracking coronavirus in Minnesota: latest map and case count. 2022.
- Minnesota Department of Health. Situation update for COVID-19; 2021. Available from: https://www.health.state.mn.us/diseases/coronavirus/situation.html
- Hamer SA, Pauvolid-Corrêa A, Zecca IB, et al. SARS-CoV-2 infections and viral isolations among serially tested cats and dogs in households with infected owners in texas, usa. Viruses. 2021;13(5):938. DOI:10.3390/v13050938
- Allendorf V, Denzin N, Conraths FJ, et al. Does having a cat in your house increase your risk of catching COVID-19? One Heal. 2021;14:100381. DOI:10.1016/j.onehlt.2022.100381
- The New York Times. Tracking Coronavirus in Texas: latest map and case count; 2022. Available from: https://www.nytimes.com/interactive/2021/us/texas-covid-cases.html
- Shi J, Wen Z, Zhong G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science. 2020;368(6494):1016–1020. DOI:10.1126/science.abb7015
- CDC. What you should know about COVID-19 and pets; 2022. Available from: https://www.cdc.gov/healthypets/covid-19/pets.html
- CDC. Confirmation of COVID-19 in two pet cats in New York; 2020. Available from: https://www.aphis.usda.gov/aphis/newsroom/news/sa_by_date/sa-2020/sars-cov-2-animals
- Health, W. O. for A. Information provided by the national veterinary services of Belgium; 2020 Mar 28. Available from: https://www.woah.org/fileadmin/Home/eng/Our_scientific_expertise/docs/pdf/COV-19/Belgium_28.03.20.pdf
- Decaro N, Grassi A, Lorusso E, et al. Long-Term persistence of neutralizing SARS-CoV-2 antibodies in pets. Transbound Emerg Dis. 2021. DOI:10.1111/tbed.14308.
- Zhang Q, Zhang H, Gao J, et al. A serological survey of SARS-CoV-2 in cat in Wuhan. Emerg Microbes Infect. 2020;9(1):2013–2019. DOI:10.1080/22221751.2020.1817796
- Klaus J, Palizzotto C, Zini E, et al. Sars-Cov-2 infection and antibody response in a symptomatic cat from Italy with intestinal b-cell lymphoma. Viruses. 2021;13(3):527. DOI:10.3390/v13030527
- Doliff R, and Martens P. Cats and SARS-CoV-2 : a scoping review. Animals. 2022;12(11):1413. https://doi.org/10.3390/ani12111413
- Dispinseri S, Secchi M, Pirillo MF, et al. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021;12(1). DOI:10.1038/s41467-021-22958-8.
- Chansaenroj J, Yorsaeng R, Puenpa J, et al. Long-Term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients. PLoS One. 2022;17(4):e0267102. DOI:10.1371/journal.pone.0267102
- Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205–1211. DOI:10.1038/s41591-021-01377-8
- Chiba S, Halfmann PJ, Hatta M, et al. Protective immunity and persistent lung sequelae in domestic cats after SARS-CoV-2 infection. Emerg Infect Dis. 2021;27(2):660–663. DOI:10.3201/eid2702.203884
- Bosco-Lauth AM, Hartwig AE, Porter SM, et al. Experimental infection of domestic dogs and cats with SARS-CoV-2: pathogenesis, transmission, and response to reexposure in cats. Proc Natl Acad Sci. 2020;117(42):26382–26388. DOI:10.1073/pnas.2013102117
- Gaudreault NN, Carossino M, Morozov I, et al. Experimental re-infected cats do not transmit SARS-CoV-2. Emerg Microbes Infect. 2021;10(1):638–650. DOI:10.1080/22221751.2021.1902753